Among them, SMO was highly expressed in glioblastoma multiforme (GBM), KIRP, NSCLC, liver hepatocellular carcinoma (LIHC), and prostate adenocarcinoma (PRAD) compared with normal tissue. This evidence concerns the gene SMO and prostate adenocarcinoma.